[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 994385, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 620894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior VP & Chief Development Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 659364, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.34, "open": 2.32, "dayLow": 2.23, "dayHigh": 2.42, "regularMarketPreviousClose": 2.34, "regularMarketOpen": 2.32, "regularMarketDayLow": 2.23, "regularMarketDayHigh": 2.42, "payoutRatio": 0.0, "beta": 2.515, "forwardPE": -7.452553, "volume": 7767482, "regularMarketVolume": 7767482, "averageVolume": 4503684, "averageVolume10days": 6723340, "averageDailyVolume10Day": 6723340, "bid": 1.95, "ask": 2.29, "bidSize": 9, "askSize": 4, "marketCap": 347963680, "fiftyTwoWeekLow": 0.85, "fiftyTwoWeekHigh": 2.48, "allTimeHigh": 718500.0, "allTimeLow": 0.5, "fiftyDayAverage": 1.799, "twoHundredDayAverage": 1.65915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 292442688, "profitMargins": 0.0, "floatShares": 141749970, "sharesOutstanding": 142442239, "sharesShort": 33260681, "sharesShortPriorMonth": 28964581, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.2335, "heldPercentInsiders": 0.00279, "heldPercentInstitutions": 0.23186001, "shortRatio": 8.96, "shortPercentOfFloat": 0.2352, "impliedSharesOutstanding": 147442240, "bookValue": 0.365, "priceToBook": 6.465753, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -25942000, "trailingEps": -0.28, "forwardEps": -0.31667, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 1.5934067, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 2.36, "targetHighPrice": 7.5, "targetLowPrice": 6.0, "targetMeanPrice": 6.83333, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 44320000, "totalCashPerShare": 0.311, "totalDebt": 599000, "quickRatio": 7.48, "currentRatio": 8.279, "debtToEquity": 1.313, "returnOnAssets": -0.44897, "returnOnEquity": -0.84334, "freeCashflow": -22079124, "operatingCashflow": -30621000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.8547, "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "regularMarketTime": 1766178001, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 2.36, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 0.42372844, "postMarketPrice": 2.37, "postMarketChange": 0.00999999, "regularMarketChange": 0.02, "regularMarketDayRange": "2.23 - 2.42", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4503684, "fiftyTwoWeekLowChange": 1.5099999, "fiftyTwoWeekLowChangePercent": 1.7764704, "fiftyTwoWeekRange": "0.85 - 2.48", "fiftyTwoWeekHighChange": -0.120000124, "fiftyTwoWeekHighChangePercent": -0.048387147, "fiftyTwoWeekChangePercent": 159.34067, "dividendDate": 1573171200, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1766192396, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.31667, "epsCurrentYear": -0.27, "priceEpsCurrentYear": -8.74074, "fiftyDayAverageChange": 0.5609999, "fiftyDayAverageChangePercent": 0.31183985, "twoHundredDayAverageChange": 0.7008499, "twoHundredDayAverageChangePercent": 0.42241502, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]